U.S. Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End Use, And Segment Forecasts, 2025 - 2033
Laboratory Corporation of America Holdings(Covance)
Albany Molecular Research(Curia)
Merck & Co., Inc.
QIAGEN
Eurofins
Evotec
GenScript BIoTech
Pharmaron
Syngene International
Dalton Pharma Services
Oncodesign
Jubilant Biosys
Domainex
Dr. Reddy Laboratories Ltd.
Pharmaron Beijing Co., Ltd.
TCG Lifesciences Pvt Ltd.
Á¦9Àå ÁÖ¿ä Ãßõ »çÇ×
LSH
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
U.S. Small Molecule Drug Discovery Outsourcing Market Summary
The U.S. small molecule drug discovery outsourcing market size was estimated at USD 1.52 billion in 2024 and is projected to reach USD 3.47 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Increasing R&D expenses, rising focus on early-stage research activities, and growing biotech companies with limited in-house resources drive the market.
Besides, outsourcing has emerged as a strategic option for pharmaceutical and biotech companies aiming to accelerate the timelines, lower fixed overhead costs, and gain access to specialized expertise in areas such as medicinal chemistry, hit-to-lead optimization, ADME/PK studies, and IND-enabling activities.
Innovations like AI-driven compound design, CRISPR-based target validation, high-throughput screening, and 3D cell models transform discovery processes, enabling contract research organizations (CROs) to provide more efficient and predictive results. Furthermore, rising R&D costs, increased demand for drug development, and a shift towards virtual pharmaceutical models support the market. In addition, an increase in registered clinical studies, a higher approval rate for small molecule drugs, advancements in medical technology, a rise in diseases being studied, and the urgent need for new treatments are anticipated to drive the market.
U.S. Small Molecule Drug Discovery Outsourcing Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. small molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, and end use:
Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Others
Service Outlook (Revenue, USD Million, 2021 - 2033)
Chemistry Services
Biology Services
Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
Respiratory system
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology companies
Academic Institutes
Table of Contents
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Workflow
1.2.2. Service
1.2.3. Therapeutics Area
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR's Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Value chain-based analysis (Model 2)
1.7.3. Multivariate Analysis (Model 3)
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Small Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for outsourcing services in drug development
3.2.1.2. Technological advancements in drug discovery